Legal Opinion
Bristol-Myers Squibb Company v. Nanocopoeia, LLC
District Court, D. Minnesota
Decided April 10, 2023No. 0:22-cv-01283Unknown
1Opinion
UNITED STATES DISTRICT COURT DISTRICT OF MINNESOTA Bristol-Myers Squibb Company, Case No. 22-cv-1283 (KMM/JFD) Plaintiff, v. ORDER Nanocopoeia, LLC, Defendant. Since 2006, Plaintiff Bristol-Myers Squibb Company has manufactured Sprycel, a drug that is used to treat certain types of leukemia. Sprycel contains the active ingredient dasatinib in the crystalline monohydrate form. Bristol-Myers has two patents that claim the crystalline form of dasatinib: the ‘725 patent and ‘103 patent.1 Defendant Nanocopoeia, a specialty pharmaceutical company based in Minneapolis, . Bristol-Myers filed this…
2Cases cited21 opinions
- Porous Media Corporation v. Pall CorporationCourt of Appeals for the Eighth Circuit · 1999
- R+L Carriers, Inc. v. DriverTech LLCCourt of Appeals for the Federal Circuit · 2012
- Ethypharm S.A. France v. Abbott LaboratoriesCourt of Appeals for the Third Circuit · 2013
- Samuel Zean v. Fairview Health ServicesCourt of Appeals for the Eighth Circuit · 2017
- Eli Lilly & Co. v. Medtronic, Inc.Supreme Court of the United States · 1990
16 more not listed; retrieve them via the Exa API.